This systematic review aims to discuss (i) the findings from analyzed data that have examined KRAS, NRAS and BRAF mutations in patients with CRC in North Africa and to compare its prevalence with that shown in other populations and (ii) the possible role of dietary and lifestyle factors with CRC risk. This evidence concerns the gene KRAS and colorectal carcinoma.